[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 3412 Introduced in House (IH)]
<DOC>
118th CONGRESS
1st Session
H. R. 3412
To authorize the Assistant Secretary for Mental Health and Substance
Use, acting through the Director of the Center for Substance Abuse
Treatment, to award grants to States to expand access to clinically
appropriate services for opioid abuse, dependence, or addiction.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
May 17, 2023
Mr. Foster introduced the following bill; which was referred to the
Committee on Energy and Commerce
_______________________________________________________________________
A BILL
To authorize the Assistant Secretary for Mental Health and Substance
Use, acting through the Director of the Center for Substance Abuse
Treatment, to award grants to States to expand access to clinically
appropriate services for opioid abuse, dependence, or addiction.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Expanding Opportunities for Recovery
Act of 2023''.
SEC. 2. OPIOID ADDICTION TREATMENT.
(a) In General.--The Assistant Secretary for Mental Health and
Substance Use, acting through the Director of the Center for Substance
Abuse Treatment (in this section referred to as the ``Assistant
Secretary'') shall award grants to States to expand access to
clinically appropriate services for opioid abuse, dependence, or
addiction.
(b) Requirements.--As conditions on the receipt of a grant under
this section, a State shall agree to comply with the following:
(1) The grant will be administered through the head of the
State's primary agency responsible for programs and activities
relating to the treatment of substance abuse.
(2) The services through the grant will be evidence-based
such as medication-assisted treatment for substance use
disorder.
(3) The services through the grant will be provided
according to a physician or a clinician's recommendation to
ensure that individuals receive the optimal level of substance
use disorder treatment for the amount of time that is deemed
medically necessary.
(4) The services through the grant will be provided
exclusively to individuals--
(A) who lack health insurance; or
(B) whose health insurance--
(i) does not cover such services; or
(ii) places other barriers on the receipt
of such services, such as--
(I) limiting coverage of such
services to a certain period of time;
or
(II) imposing nonquantitative
treatment limitations that are more
stringent than treatment limitations
imposed on other medical conditions
(such as a requirement to use less
expensive services, like outpatient
treatment, prior to more expensive, but
physician-recommended services, such as
inpatient or residential treatment).
(5) The grant will not be used to pay or subsidize the cost
of more than 60 consecutive days of opioid abuse, dependence,
or addiction treatment in the case of any individual.
(c) Permissible Provision of Medications.--In expanding access to
clinically appropriate services for opioid abuse, dependence, or
addiction through a grant under this section, a State may provide for
the use of medications, in conjunction with other treatment, so long as
the medications--
(1) are lawfully marketed under the Federal Food, Drug, and
Cosmetic Act (21 U.S.C. 301 et seq.);
(2) are clinically indicated to address the abuse,
dependence, or addiction; and
(3) are offered consistent with consumer choice.
(d) Coordination.--The Assistant Secretary shall coordinate the
program under this section with the program for prevention and
treatment of substance abuse under subpart II of part B of title XIX of
the Public Health Service Act (42 U.S.C. 300x-21 et seq.).
(e) Evaluation; Dissemination of Information; Technical
Assistance.--
(1) In general.--The Assistant Secretary shall--
(A) require States receiving a grant under this
section to report appropriate outcome measures
associated with use of the grant, including any--
(i) decreases in substance use;
(ii) changes in retention in care;
(iii) connections to the next appropriate
level of care;
(iv) decreases in involvement with criminal
justice activities; and
(v) other outcome data as appropriate;
(B) require States receiving a grant under this
section to report data on individuals' length of time
under clinically appropriate addiction treatment, and
the use of medication-assisted treatment;
(C) evaluate the activities supported by grants
under this section;
(D) submit to the Congress and the Secretary, and
make publicly available on the internet site of the
Substance Abuse and Mental Health Services
Administration, information about the results of such
evaluation; and
(E) offer technical assistance to States receiving
a grant under this section regarding activities funded
through the grant.
(2) Use of certain funds.--Of the funds appropriated to
carry out this section for any fiscal year, 5 percent shall be
available to carry out activities under this subsection.
<all>